Summary
This narrative review synthesises current knowledge on the biochemical composition and purported health benefits of microgreens—immature plants harvested 7–21 days post-germination from commercial crop species. The authors emphasise the nutrient density and bioactive compound richness of microgreens relative to mature vegetables, and propose their potential application in prevention of diet-related chronic diseases and malnutrition, though the review is primarily descriptive rather than providing quantitative meta-analytical evidence.
Regional applicability
The review does not report a specific geographical study location and addresses microgreens as an emerging global food category. Applicability to United Kingdom practice depends on local microgreens production systems and consumer accessibility; the evidence base cited may include studies from diverse geographies and climates. Transferability is high given the controlled nature of microgreens cultivation, though UK-specific agronomic and supply chain factors are not addressed.
Key measures
Concentrations of ascorbic acid, tocopherols, carotenoids, folate, tocotrienols, phylloquinones, anthocyanins, glucosinolates; qualitative assessment of health benefits in prevention of inflammation and chronic disease
Outcomes reported
The review catalogues bioactive molecules (vitamins, minerals, phytochemicals) present in microgreens and evaluates their potential role in prevention of chronic non-communicable diseases. It synthesises evidence on nutritional density and functional properties of microgreens across commercial crop varieties.
Topic tags
Dig deeper with Pulse AI.
Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.